tiprankstipranks
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market

Elite Pharmaceuticals (ELTP) Technical Analysis

128 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
3Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Elite Pharmaceuticals’s (ELTP) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Elite Pharmaceuticals is a Sell.
Elite Pharmaceuticals’s (ELTP) 20-Day exponential moving average is 0.19, while Elite Pharmaceuticals’s (ELTP) share price is $0.199, making it a Buy.
Elite Pharmaceuticals’s (ELTP) 50-Day exponential moving average is 0.17, while Elite Pharmaceuticals’s (ELTP) share price is $0.199, making it a Buy.

Elite Pharmaceuticals (ELTP) Pivot Points

Jul 22, 2024, 03:02 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.18
0.19
0.19
0.20
0.20
0.21
0.21
Fibonacci
0.19
0.19
0.19
0.20
0.20
0.20
0.21
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Elite Pharmaceuticals (ELTP) Moving Averages

Jul 22, 2024, 03:02 AM
Period
Simple
Exponential
MA5
0.20Buy
0.20Buy
MA10
0.19Buy
0.19Buy
MA20
0.19Buy
0.19Buy
MA50
0.17Buy
0.17Buy
MA100
0.16Buy
0.16Buy
MA200
0.15Buy
0.14Buy
Elite Pharmaceuticals’s (ELTP) 10-Day exponential moving average is 0.19, while Elite Pharmaceuticals’s (ELTP) share price is $0.199, making it a Buy.
Elite Pharmaceuticals’s (ELTP) 100-Day exponential moving average is 0.16, while Elite Pharmaceuticals’s (ELTP) share price is $0.199, making it a Buy.
Elite Pharmaceuticals’s (ELTP) stock price is $0.199 and Elite Pharmaceuticals’s (ELTP) 50-day simple moving average is 0.17, creating a Buy signal.
Elite Pharmaceuticals’s (ELTP) stock price is $0.199 and Elite Pharmaceuticals’s (ELTP) 100-day simple moving average is 0.16, creating a Buy signal.
Elite Pharmaceuticals’s (ELTP) stock price is $0.199 and Elite Pharmaceuticals’s (ELTP) 200-day simple moving average is 0.15, creating a Buy signal.

Elite Pharmaceuticals (ELTP) Technical Indicators

Jul 22, 2024, 03:02 AM
Name
Value
Implied Action
RSI (14)
65.23
Neutral
STOCH (9,6)
93.16
Sell
STOCHRSI (14)
77.78
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
33.66
Neutral
Williams %R
-22.22
Buy
CCI (14)
97.19
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
85.39
Buy
ROC
0.00
-
Elite Pharmaceuticals’s (ELTP) Relative Strength Index (RSI) is 65.23, creating a Neutral signal.
Elite Pharmaceuticals’s (ELTP) Trend Strength Indicator (ADX) is 33.66, creating a Neutral signal.
Elite Pharmaceuticals’s (ELTP) Commodity Channel Index (CCI) is 97.19, creating a Neutral signal.

FAQ

Is ELTP a Buy, Hold, or Sell?
Based on ELTP’s technical indicators, ELTP is a Strong Buy.
    What is ELTP’s RSI (14)?
    ELTP’s RSI (14) is 65.23, which suggests ELTP is a Neutral.
      What is ELTP’s MACD?
      ELTP’s MACD is <0.01, which suggests ELTP is a Sell.
        What is ELTP’s 5-day moving average?
        ELTP’s 5-day moving average is 0.20, which suggests ELTP is a Buy.
          What is ELTP’s 20-day moving average?
          ELTP 20-day moving average is 0.19, which suggests ELTP is a Buy.
            What is ELTP’s 50-day moving average?
            ELTP’s 50-day moving average is 0.17, which suggests ELTP is a Buy.
              What is ELTP’s 200-day moving average?
              ELTP’s 200-day moving average is 0.15, which suggests ELTP is a Buy.
                What is ELTP’s Williams % R (14)?
                ELTP’s Williams % R (14) is -22.22, which suggests ELTP is a Buy.
                  What is ELTP’s CCI (14)?
                  ELTP’s CCI (14) is 97.19, which suggests ELTP is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis